Monthly Archives: December 2020

Patients with inflammatory bowel disease (IBD) have an increased risk of colorectal cancer (CRC). We performed a systematic review and meta-analysis to identify all prognostic factors for advanced colorectal neoplasia (aCRN, high-grade dysplasia or CRC… Continue reading →

Dr. Jeff Balser, President and CEO, and Dr. Wright Pinson, Deputy CEO, share an update about the Medical Center’s response to the bombing’s impact on landline telephone services provided through AT&T. Continue reading →

Polygenic risk scores (PRS) may soon be used to predict inflammatory bowel disease (IBD) risk in prevention efforts. We leveraged exome-sequence and SNP array data from 29,358 individuals in the multi-ethnic, randomly-ascertained health system-based Bi… Continue reading →

A snapshot of some of the numbers that help tell the story of COVID-19 at Vanderbilt. Continue reading →

Health care workers, who have been disproportionately affected by the COVID-19 pandemic, will be the first tier of Vanderbilt University Medical Center employees to receive vaccine to prevent SARS-CoV-2 infection.
VUMC, which started administering the … Continue reading →

As COVID-19 vaccination has begun across VUMC, it is important to be aware of the following considerations as appointments are scheduled. Continue reading →

Santa isn’t the only one receiving handwritten letters from children this holiday season. Cards to VUMC’s front-line workers from local schoolchildren also bring special greetings, including “You deserve 100 million candy canes.” Continue reading →

In the first days of the workforce COVID-19 vaccination effort, more than 3,000 vaccinations have been given. More than 15,000 members of VUMC’s workforce have enrolled to receive vaccine. Continue reading →